Member Info for inanaco

The research i did yesterday by asking questions from scancell in such a way as it did not appear as price sensitive gave us Clarity on the current position, and instantly removed any negative sentiment. So posters should build back on that foundation. Scancells science is Mega ... you do not need to hype anything

You want harmony and this is harmony ?? C7 you cannot defend what you post, even if i had posted what you had written, i would be unable to defend it .... so basically get over it. """"drastic changes in market conditions and progress we have seen around us has IMHO caused us to re evaluate and perfect our treatments accordingly.""" what does that mean ?? scancell has done nothing of the sort ''I am very sympathetic to the restrictions that can delay news. I just hope that Scancell are as aware that traders and Pis should know certain information. I dont think in the last three years we have found that balance.'' I assume that relates to the demand for price sensitive information to be released ahead of time, Its never going to happen. """Secondly as explained frequently, words about me which you have eagerly posted will never be forgotten. """ who are you ? what sort of message does that send out ?? I believe in free speech 100%, however i also believe in others free speech, posts have been highlighted as "suspect" its your right to defend them, but you cannot Smart move is withdraw them ... Rats you cannot plug a sinking ship with a wine cork.

who has promised an update ?

we have no idea, as discussions are done under NDA. what i can say .. as per RNS discussions with somebody is ongoing, but again that will be under NDA

well email is from scancell ....

Investor day 2013 Richard CEO preferred partner Roche ... can you remember Wild ?

i cannot fathom why anyone would sell for a 10% profit or so when you have Roche sitting in the next room about to join in with the CRUK program ... its a $183 billion company ...

actually its Roche .... still have no idea what they are doing ........... Genentech

wild ... we missed that with janseen ... ""Europe"" my mind now is completely at ease ... case of buy buy buy ....

first, Richard is still a director and on the website its states "commercial" the collaboration agreement has a commercial option, but until the science has shown its full effect it would be unwise of both parties to commit, once this is done a better True value of how valuable using the Modi 1 epitopes can be exploited SCIB1 .......... the added value comes with Synergy with PD1 .. simple as that SCIB2 ... sorted Modi1 trails value can then be attributed to actual efficacy in patients Delay in doing deals only moves us further along the trial paths .. the numbers just get bigger.

To ease investors ref any current delay Its the regulatory pathway is causing the delay of the ichor device in the US the janseen trial is in Europe https://clinicaltrials.gov/ct2/show/NCT03463369 ichor is approved in Europe for the next gen gun. All is ok for us to use that Gun, and the IND is on track in the US There is no problem of supply for the new gun for the trial.

but tactical would be better LOL

or a tactile play by the market makers to get more shares for the coming RNS hardly any about still

https://www.researchcancerimmunotherapy.com/foundational-science/immune-phenotypes you see the environment inflammation .... but tired t cells ... welcome to SCIB1 with High Avidity T cells ...

https://www.fda.gov/Drugs/DevelopmentApprovalProcess/HowDrugsareDevelopedandApproved/ApprovalApplications/InvestigationalNewDrugINDApplication/default.htm

Application There are three IND types: An Investigator IND is submitted by a physician who both initiates and conducts an investigation, and under whose immediate direction the investigational drug is administered or dispensed. A physician might submit a research IND to propose studying an unapproved drug, or an approved product for a new indication or in a new patient population. Emergency Use IND allows the FDA to authorize use of an experimental drug in an emergency situation that does not allow time for submission of an IND in accordance with 21CFR , Sec. 312.23 or Sec. 312.20. It is also used for patients who do not meet the criteria of an existing study protocol, or if an approved study protocol does not exist. Treatment IND is submitted for experimental drugs showing promise in clinical testing for serious or immediately life-threatening conditions while the final clinical work is conducted and the FDA review takes place.

is only 30 days ....... Once the IND is submitted, the sponsor must wait 30 calendar days before initiating any clinical trials. During this time, FDA has an opportunity to review the IND for safety to assure that research subjects will not be subjected to unreasonable risk.

the underlying science of the immune system is complex which is what confuses most, all these macrophages antibodies, cytokines, cd4, cd8 cd4 Plus cd8 Plus .. memory cells .. blah blah millions of years of progression through diversity of the genome .. but break it down to inflammation and interferon gamma . and that is the immune system kicking in .... that is all scancell is doing , but the clever bit from Lindy is she understood the process ... way ahead of any other team.

over complication ? its all about inflammation ... that is it No Magic all Scancell has done is harness the best natural approach to achieve it, which is why the science is so good. over complicating the science is adding layer upon layer, the posts highlighted that yesterday Mrna why complicate when you already have a 100% cancer kill in the mouse its traders taking a bit of profit .... and as night follows day ... a bottom will reach and probably very soon prompting another push from the plains of India to the eventual Hill called Everest .

it is a nothing RNS .. but the spread is 22% ... its seems it moved away from a treatment for cancer to a quality of life product ...but then its based on Risperidone ..... so which is working ? Risperdone or Val 401 but with such a small sample size, and duration of treatment, I just don't see how they can pull out any useful data indeed you can generate all sorts of results from such a small number and make claims ... but that does not mean its been successful The IMM trial showed that ... the placebo effect can be quite extraordinary in the "feel Good factor" or "Quality of Life" Still investors are happy ... they have an RNS which drives sentiment